Extension of Time to File SOU

XIPERE

Clearside Biomedical, Inc.

Request for Extension of Time to File a Statement of Use

Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88221046
LAW OFFICE ASSIGNED LAW OFFICE 121
MARK SECTION
MARK http://uspto.report/TM/88221046/mark.png (stylized and/or with design)
STANDARD CHARACTERS NO
USPTO-GENERATED IMAGE NO
OWNER SECTION (current)
NAME Clearside Biomedical, Inc.
MAILING ADDRESS 900 North Point Parkway, Suite 200
CITY Alpharetta
STATE Georgia
ZIP/POSTAL CODE 30005
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
OWNER SECTION (proposed)
NAME Clearside Biomedical, Inc.
MAILING ADDRESS 900 North Point Parkway, Suite 200
CITY Alpharetta
STATE Georgia
ZIP/POSTAL CODE 30005
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME BASSAM N. IBRAHIM
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE bassam.ibrahim@bipc.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) NOT PROVIDED
DOCKET/REFERENCE NUMBER 0080003-115
CORRESPONDENCE INFORMATION (proposed)
NAME Bassam N. Ibrahim
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE bassam.ibrahim@bipc.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kathy.bazil@bipc.com
DOCKET/REFERENCE NUMBER 0080003-115
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Ocular pharmaceuticals; Ophthalmic preparations
GOODS OR SERVICES KEEP ALL LISTED
INTERNATIONAL CLASS 010
CURRENT IDENTIFICATION Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 2
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 06/11/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 2
SUBTOTAL AMOUNT [EXTENSION FEE] 250
TOTAL AMOUNT 250
SIGNATURE SECTION
       ORIGINAL PDF FILE hw_1992474448-121053832_. _416_-_XIPERE__Stylied__- _Signed_Dec_Second_Extens ion_of_Time.pdf
       CONVERTED PDF FILE(S)
       (2 pages)
\\TICRS\EXPORT18\IMAGEOUT 18\882\210\88221046\xml1\ ESU0002.JPG
        \\TICRS\EXPORT18\IMAGEOUT 18\882\210\88221046\xml1\ ESU0003.JPG
SIGNATORY'S NAME Leslie Zacks
SIGNATORY'S POSITION General Counsel
FILING INFORMATION
SUBMIT DATE Fri Apr 24 12:16:47 ET 2020
TEAS STAMP USPTO/ESU-XXX.XXX.XX.XX-2
0200424121647991752-88221
046-710ea3c7cd7dc19d2c677
2af8ef653e1c71c578410d23c
42469fb47a9aeb4acb-CC-164
63111-2020042412105383201
5



Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1581 (Rev 09/2005)
OMB No. 0651-0054 (Exp 12/31/2020)


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: XIPERE (stylized and/or with design, see http://uspto.report/TM/88221046/mark.png)
SERIAL NUMBER: 88221046

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: Clearside Biomedical, Inc., having an address of
      900 North Point Parkway, Suite 200
      Alpharetta, Georgia 30005
      United States
Proposed: Clearside Biomedical, Inc., having an address of
      900 North Point Parkway, Suite 200
      Alpharetta, Georgia 30005
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 06/11/2019.

For International Class 005:
Current identification: Ocular pharmaceuticals; Ophthalmic preparations

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


For International Class 010:
Current identification: Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the second extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      BASSAM N. IBRAHIM
      PRIMARY EMAIL FOR CORRESPONDENCE: bassam.ibrahim@bipc.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): NOT PROVIDED

Correspondence Information (proposed):
      Bassam N. Ibrahim
      PRIMARY EMAIL FOR CORRESPONDENCE: bassam.ibrahim@bipc.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kathy.bazil@bipc.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $250 will be submitted with the form, representing payment for 2 classes.


Declaration



Original PDF file:
hw_1992474448-121053832_. _416_-_XIPERE__Stylied__- _Signed_Dec_Second_Extens ion_of_Time.pdf
Converted PDF file(s) (2 pages)
Signature File1
Signature File2

Signatory's Name: Leslie Zacks
Signatory's Position: General Counsel

RAM Sale Number: 88221046
RAM Accounting Date: 04/24/2020

Serial Number: 88221046
Internet Transmission Date: Fri Apr 24 12:16:47 ET 2020
TEAS Stamp: USPTO/ESU-XXX.XXX.XX.XX-2020042412164799
1752-88221046-710ea3c7cd7dc19d2c6772af8e
f653e1c71c578410d23c42469fb47a9aeb4acb-C
C-16463111-20200424121053832015



Extension of Time to File SOU [image/jpeg]

Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed